GL1X · GenesisL1 explorer

Ligand · C8E

C8E · (hydroxyethyloxy)tri(ethyloxy)octane

C8E, (hydroxyethyloxy)tri(ethyloxy)octane (C16 H34 O5, 306.4 g/mol), in the MolNFT structures on GenesisL1: bound in 113 records (77 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds most and the…

Component
C8E
Formula
C16 H34 O5
Class
additive
Structures
113
PDB entries
77

Binding sites

C8E in 113 structures; the first of them:

  • 5DL5 · Crystal structure of Acinetobacter baumannii OccAB1 · C8E A501 · binds ARG26, GLY76, ASN77, GLN78, LYS82, ARG126, TYR307, MET308 and 2 more
  • 5DL7 · Crystal structure of Acinetobacter baumannii OccAB3 · C8E A505 · binds GLN261, HIS263, TYR309, TYR311, PHE313, LEU326, PHE328
  • 5DL8 · Crystal structure of Acinetobacter baumannii OccAB4 · C8E B401 · binds TYR352, PHE354, GLN356
  • 5EGF · The crystal structure of SeMet-CT · C8E A508 · binds VAL244, PRO245, PHE246, LEU300, SER386, VAL433, VAL454, LEU455 and 4 more
  • 5FOK · Crystal structure of the siderophore receptor PiuA from Pseudomonas aeruginosa · C8E A1721 · binds ASN289, ASP290, ASN291, ALA346, ASN347, PHE348
  • 5FP1 · Crystal structure of the siderophore receptor PiuA from Acinetobacter baumannii · C8E A1717 · binds ILE471, ILE481, TYR482, THR483, ILE522
  • 5FQ8 · Crystal structure of the SusCD complex BT2261-2264 from Bacteroides thetaiotaomicron · C8E B1989 · binds PHE976

Residues it binds most

TYR 613, PHE 511, LEU 406, GLY 389, VAL 347, ALA 347, ILE 257, ASP 196, ASN 192, THR 169 (residue and the binding sites it lines).

Found with

  • SO4 · Sulfate ion
  • NA · Sodium ion
  • MG · Magnesium ion
  • CA · Calcium ion
  • LDA · Lauryl dimethylamine-N-oxide
  • EDO · 1,2-ethanediol
  • LMT · Dodecyl-beta-D-maltoside
  • 3PE · 1,2-diacyl-sn-glycero-3-phosphoethanolamine
  • PLM · Palmitic acid
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose
  • PO4 · Phosphate ion
  • GOL · Glycerol

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.